Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.76% | 1.37% | 6.56% | -0.29% | -0.68% |
| Total Depreciation and Amortization | 14.59% | 15.98% | 21.23% | 16.59% | 12.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.60% | 957.93% | -11.71% | 193.32% | 157.09% |
| Change in Net Operating Assets | 60.97% | 47.36% | 45.45% | 1.84% | -46.92% |
| Cash from Operations | 16.80% | 68.75% | 66.83% | 19.51% | -0.70% |
| Capital Expenditure | 18.99% | -1.41% | -20.45% | -59.90% | -64.04% |
| Sale of Property, Plant, and Equipment | -44.30% | -76.26% | -76.10% | -72.71% | -52.32% |
| Cash Acquisitions | 94.74% | 96.89% | 96.89% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -265.53% | -219.73% | -462.09% | 170.69% | 187.60% |
| Cash from Investing | -5.88% | 10.26% | 31.14% | -6.65% | -41.72% |
| Total Debt Issued | -17.28% | -77.31% | -101.18% | -12.86% | 163.53% |
| Total Debt Repaid | 2.32% | 15.38% | -269.74% | -189.47% | 73.84% |
| Issuance of Common Stock | 105.70% | 54.46% | 64.47% | -50.34% | -76.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.10% | 4.10% | 4.10% | 1.09% | 1.09% |
| Other Financing Activities | -224.29% | -208.04% | -197.76% | 229.76% | 257.68% |
| Cash from Financing | -62.14% | -123.68% | -142.06% | 16.54% | 597.54% |
| Foreign Exchange rate Adjustments | 431.72% | 1,309.01% | 543.88% | 698.99% | 454.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.42% | -6.14% | 40.79% | 281.55% | 430.31% |